O ρόλος της Ομοιοπαθητικής στον Καρκίνο  είναι :
η ενίσχυση των μηχανισμών άμυνας του οργανισμού σύμφωνα με τα σύγχρονα δεδομένα της ανοσολογίας,
η υποβοήθηση των ομοιοστατικών μηχανισμών σύμφωνα με τα σύγχρονα δεδομένα της παθολογικής φυσιολογίας,
η ψυχοσωματική στήριξη των ασθενών σύμφωνα με τα σύγχρονα δεδομένα της ψυχο-ογκολογίας
η εξυγίανση του μικροπεριβάλλοντος των κυττάρων.Το μικροπεριβάλλον των  κυττάρων (Matrix)  σήμερα θεωρείται απο την Κλασσική Έρευνα του Καρκίνου  σημαντικός παράγων για την ανάπτυξη καρκινικών κυττάρων  και για την επέκταση τους τοπικά ή και σε όλο τον οργανισμό .


Η συχνότητα του καρκίνου αυξάνεται προοδευτικά και σε όλο και πιο επιθετικές μορφές. Τα ποσοστά θνησιμότητας δεν έχουν αλλάξει εδώ και δεκαετίες για τις περισσότερες περιπτώσεις καρκίνου. Επιπλέον, ένα μεγάλο ποσοστό καρκινοπαθών υποφέρει από σοβαρές παρενέργειες της θεραπείας τους.Η αντίληψη  ότι τα καρκινικά κύτταρα είναι το αποκλειστικό «κακό» που πρέπει να αφαιρεθεί και/ή να καταστραφεί, έχει οδηγήσει σε πολλές παρερμηνείες και ταλαιπωρίες. Σύμφωνα με τη σύγχρονη Φυσιολογία και Βιολογία, ο Καρκίνος πρέπει να αντιμετωπιστεί από μια εντελώς διαφορετική οπτική γωνία. Τα καρκινικά κύτταρα δεν είναι το μόνο και αποκλειστικό πρόβλημα. Πρωτίστως, το πρόβλημα είναι το κακο  περιβάλλον των κυττάρων ή αλλιώς η παθολογία της εξωκυτταρικής ουσίας των ιστών, που ενθαρρύνει την ανάπτυξη καρκινικών κυττάρων. Τα νεοπλασματικά κύτταρα είναι υποπροϊόν της όλης διαδικασίας καρκινογένεσης και όχι η αρχική ή η αποκλειστική βλάβη του ιστού όπου αναπτύσσεται η διαδικασία της καρκινογενεσης και της προοδου της νοσου. Έτσι, οποιαδήποτε ολοκληρωμένη θεραπεία θα πρέπει να αντιμετωπίζει οπωσδήποτε και τις συνθήκες που προκάλεσαν τη νόσο και μαλιστα  χωρίς να βλάπτει την υγεία του οργανισμού στο συνολό του.


Η κλινικά προσανατολισμένη Ομοιοπαθητική  Φαρμακολογία έχει τη δυνατότητα να απευθύνεται στοχευμένα  σε ολους τους μηχανισμούς που υπεισερχονται στην παθογένεια και εξέλιξη της νόσου και να επηρεάζει ουσιαστικά και θετικά την πρόγνωση και την πορεία της νόσου και της συνολικής υγείας του ασθενούς.Ο Δρ Τάσος Βαρθολομαίος έχει αναπτύξει ιδιαίτερα αυτό το κεφάλαιο της Ομοιοπαθητικής Φαρμακολογίας ,διαμορφώνοντας μια μοναδική προσεγγιση,που αποδιδεται διεθνώς με τον όρο «ΟΜΟΙΟΠΑΘΟΛΟΓΙΑ» (Homoeopathology).

 
Η Ομοιοπαθητική θα πρέπει να ξεκινάει το ταχύτερο δυνατόν μετα τη διάγνωση του καρκίνου,ανεξαρτητα απο οποιοδήποτε συμβατικό θεραπευτικό σχεδιασμό και παράλληλα με αυτόν .
 

Σε κάθε περίπτωση ,στην "Ομοιοπαθητική Φροντίδα Υγείας" γίνεται εμπεριστατωμένη μελέτη τόσο των Εργαστηριακών εξετάσεων (βιοψίες, καρκινικοι δεικτες,απεικονιστικες εξετασεις,κτλ) όσο και του πλήρους ιστορικού για τη διερεύνηση και αποσαφήνιση των αιτίων και της παθογένειας της ανάπτυξης καρκίνου σε κάθε μια ξεχωριστή περίπτωση. Αυτή η διερεύνηση είναι καθοριστικής σημασίας για τη συνολική και ολοκληρωμένη ομοιοπαθητική αντιμετώπιση του κάθε περιστατικού ,δεδομένου ότι σαν μέθοδος ανάλυσης του ιστορικού ,κτλ χρησιμοποιείται η Ομοιοπαθητική, με το πλουσιότατο αναλυτικό υλικό της.
 

ΩΣ ΙΑΤΡΟΣ ΙΣΤΟΠΑΘΟΛΟΓΟΣ (ΠΑΘΟΛΟΓΟΑΝΑΤΟΜΟΣ),
ο Δρ Τάσος Βαρθολομαίος μπορεί επιπλέον να σας δώσει τη Συμβουλή του πάνω στις ΙΣΤΟΛΟΓΙΚΕΣ (ΠΑΘΟΛΟΓΟΑΝΑΤΟΜΙΚΕΣ) ΕΞΕΤΑΣΕΙΣ που εχουν γίνει ,σε συνδυασμό με το Κλινικό Ιατρικό και το Ομοιοπαθητικό ιστορικό σας και τις λοιπους Κλινικο-Εργαστηριακούς Ελέγχους που έχετε κάνει.
 

ΕΝΗΜΕΡΩΣΗ για τον ΚΑΡΚΙΝΟ
ΑΠΟ  ΙΑΤΡΙΚΕΣ,ΒΙΟΛΟΓΙΚΕΣ ΠΗΓΕΣ και απο   τον ΔΙΕΘΝΗ   ΤΥΠΟ
 

Κυτταροτοξική δράση Ομοιοπαθητικών σκευασμάτων σε κακοήθη κύτταρα Καρκίνου του Μαστού

Eπειδή η χρήση Ομοιοπαθητικών σκευασμάτων στην θεραπευτική του καρκίνου έχει προκαλέσει μεγάλο ενδιαφέρον, μελετήθηκε σε Κέντρο Έρευνας του Καρκίνου στο Πανεπιστήμιο του Τέξας η δράση τεσσάρων εξαιρετικά αραιωμένων Ομοιοπαθητικών σκευασμάτων σε κύτταρα αδενοκαρκινώματος μαστού (MCF-7 και MDA-MB-231). Τα Ομοιοπαθητικά αυτά σκευάσματα φάνηκε ότι έχουν εκλεκτική κυτταροτοξική δράση στα κακοήθη κύτταρα απο καρκίνο του μαστού, προκαλώντας καθυστέρηση στον κυτταρικό τους κύκλο και αυξημένη απόπτωση (κυτταρικό θάνατο). Τα ευρήματα αυτά δείχνουν, κατά τους ερευνητές, αξιόλογη βιολογική δραστικότητα αυτών των φυσικών προϊόντων σε εξαιρετικά αραιωμένες (ομοιοπαθητικές) δόσεις. Περαιτέρω μελέτες σε βάθος, με επιπρόσθετες κυτταρικές σειρές και σε ζωικά μοντέλα, δικαιολογείται, σύμφωνα με την έρευνα, για να διερευνηθεί η κλινική εφαρμοσιμότητα αυτών των Ομοιοπαθητικών σκευασμάτων σε ασθενείς.
Παρατίθεται η βιβλιογραφικη αναφορά από το διαδίκτυο:
Τίτλος: Cytotoxic effects of ultra-diluted remedies on breast cancer cells
Συγγραφείς: Moshe Frenkel, Bal Mukund Mishra, Subrata Sen, Peiying Yang, Alison Pawlus, Luis Vence, Aimee Leblanc, Lorenzo Cohen, Pratip Banerji, Prasanta Banerji
Eρευνητικό Πρόγραμμα/Κέντρο: Integrative Medicine Program-Unit 145, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA. frenkelm@netvision.net.il
Ιατρικό Περιοδικό: International Journal of Oncology, 2010 Feb;36(2):395-403
Πλήρες Κείμενο του Άρθρου στην ιστοσελίδα:
http://www.audesapere.in/researchstudies/fr/pdf/Int%20J%20Oncol%20Vol36%20No2%20Pg395%20(1).pdf


Cancer: The mysterious miracle cases inspiring doctors
6 March 2015
ΠΗΓΗ:https://www.bbc.com/future/article/20150306-the-mystery-of-vanishing-cancer
David Robson
Features correspondent
A few patients have made rare and unexpected recoveries leaving doctors scratching their heads, says David Robson. Can these cases provide vital clues for tackling cancer?
It was a case that baffled everyone involved. The 74-year-old woman had initially been troubled by a rash that wouldn’t go away. By the time she arrived at the hospital, her lower right leg was covered in waxy lumps, eruptions of angry red and livid purple. Tests confirmed the worst suspicions: it was carcinoma, a form of skin cancer.
The future looked bleak. Given the spread of the tumours, radiotherapy would not have been effective; nor could the doctors dig the tumours from the skin. Amputation was perhaps the best option, says Alan Irvine, the patient’s doctor at St James’ Hospital, Dublin – but at her age, she was unlikely to adapt well to a prosthetic limb. After a long and frank discussion, they decided to wait as they weighed up the options. “We had a lot of agonising for what to do,” says Irvine.
Then the “miracle” started. Despite receiving no treatment at all, the tumours were shrinking and shrivelling before their eyes. “We watched for a period of a few months and the tumours just disappeared,” says Irvine. After 20 weeks, the patient was cancer-free. “There had been no doubt about her diagnosis,” he says. “But now there was nothing in the biopsies, or the scans.”
Somehow, she had healed herself of arguably our most feared disease. “Everyone was thrilled, and a bit puzzled,” Irvine says, with some understatement. “It shows that it is possible for the body to clear cancer – even if it is incredibly rare.”
The question is, how? Irvine’s patient believed it was the hand of God; she had kissed a religious relic just before the healing set in. But scientists are instead looking to the underlying biology of so-called “spontaneous regression” to hunt for clues that could make these rare cases of self-healing more common. “If you can train the body to do this on a broader scale, you could have something that’s very widely applicable,” says Irvine.
In theory, our immune system should hunt out and destroy mutated cells before they ever develop into cancer. Occasionally, however, these cells manage to sneak under the radar, reproducing until they grow into a full-blown tumour.
By the time the cancer has reached the attention of doctors, unaided recovery is highly unlikely: overall, just one in 100,000 cancer patients are thought to shed the disease without treatment.
Disappearing act
Within those scant reports, though, there are some truly incredible stories. A hospital in the UK, for instance, recently reported the case of a woman who had experienced long-lasting fertility problems. She then discovered that she had a tumour between her rectum and her uterus, but before doctors could operate, she finally conceived. All went well and a healthy baby was delivered – only for the doctors to find that the cancer had mysteriously vanished during the pregnancy. Nine years later, she shows no sign of relapse.
Similarly spectacular recoveries have now been recorded in many different kinds of cancer, including extremely aggressive forms like acute myeloid leukaemia, which involves the abnormal growth of white blood cells. “If you leave the patient untreated, they usually die within weeks, if not days,” says Armin Rashidi at Washington University in St Louis. Yet he has found 46 cases in which acute myeloid leukaemia regressed of its own accord, although only eight avoided a relapse in the long term. “If you find a random oncologist and ask if this can this happen, 99% would say no – it makes no sense,” says Rashidi, who worked with colleague Stephen Fisher on the paper.
Agonising wait
In contrast, dramatic recoveries from a childhood cancer called neuroblastoma are surprisingly frequent – offering some of the best clues about what might trigger spontaneous remission. This cancer arises from tumours in the nervous system and hormonal glands. If it then spreads, or metastasises, it can lead to nodules on the skin and growths in the liver, with swelling in the abdomen that makes it difficult for the infant to breathe.
Neuroblastoma is very distressing, yet it can sometimes disappear as quickly as it came, even without medical intervention. In fact, for infants less than one year old, regression is so common that doctors tend to avoid starting chemotherapy immediately, in the hope that the tumour will shrink by itself. “I can remember three cases with rather impressive skin metastases and an enlarged liver, but we literally just observed them – and they did well,” says Garrett Brodeur at the Children’s Hospital of Philadelphia.
The decision to sit and observe can be difficult, though: although the chance to avoid harrowing treatment comes as a relief to some parents, others find inaction and helplessness difficult to stomach. The agony of that period is one of the reasons that Brodeur wants to understand the mechanisms behind the cancer’s vanishing act. “We want to develop very specific agents that might initiate regression – so we don’t need to wait for nature to run its course or for ‘god’ to decide,” he says. 
Vital clues
So far, Brodeur has some strong leads. For instance, unlike other nerve cells, the cells in neuroblastoma tumours seem to have developed the ability to survive without “nerve growth factor” (NGF) – allowing them to flourish in the wrong parts of the body where NGF is absent. Spontaneous remission may be triggered by a natural change in the neuroblastoma tumour cells, perhaps involving the cell receptors that NGF binds to. Whatever the change is, it might mean that the cells can no longer survive without the essential nutrient.
If so, a drug that targets those receptors could kick-start recovery in other patients. Brodeur says that two drug companies already have some candidates, and he hopes trials will begin soon. “It would selectively kill tumour cells that are sensitive to this pathway, so it could spare patients from chemotherapy, radiotherapy or surgery,” he says. “It wouldn’t make them sick or their hair fall out, or cause their blood cell count to fall.”
Friendly fire
Unfortunately, unexpected recoveries from other kinds of cancer have been less well studied, perhaps because of their rarity. But there are some clues, and they could come from the pioneering work of a little-known American doctor more than 100 years ago.
It was the late 19th Century, and William Bradley Coley was struggling to save a patient with a large tumour in his neck. Five operations had failed to eradicate the cancer. Then the patient caught a nasty skin infection with a scorching fever. By the time he’d recovered, the tumour was gone. Testing the principle on a small number of other patients, Coley found that deliberately infecting them with bacteria, or treating them with toxins harvested from microbes, destroyed otherwise inoperable tumours.
Unfortunately, unexpected recoveries from other kinds of cancer have been less well studied, perhaps because of their rarity. But there are some clues, and they could come from the pioneering work of a little-known American doctor more than 100 years ago.
It was the late 19th Century, and William Bradley Coley was struggling to save a patient with a large tumour in his neck. Five operations had failed to eradicate the cancer. Then the patient caught a nasty skin infection with a scorching fever. By the time he’d recovered, the tumour was gone. Testing the principle on a small number of other patients, Coley found that deliberately infecting them with bacteria, or treating them with toxins harvested from microbes, destroyed otherwise inoperable tumours.
Could infection be the key to stimulating spontaneous remission more generally? Analyses of the recent evidence certainly make a compelling case for exploring the idea. Rashidi and Fisher’s study found that 90% of the patients recovering from leukaemia had suffered another illness such as pneumonia shortly before the cancer disappeared. Other papers have noted tumours vanishing after diphtheria, gonorrhoea, hepatitis, influenza, malaria, measles, smallpox and syphilis. What doesn’t kill you really can make you stronger in these strange circumstances.
It’s not the microbes, per se, that bring about the healing; rather, the infection is thought to trigger an immune response that is inhospitable to the tumour. The heat of the fever, for instance, may itself render the tumour cells more vulnerable, and trigger cell suicide. Or perhaps it’s significant that when we are fighting bacteria or viruses, our blood is awash with inflammatory molecules that are a call to arms for the body’s macrophages, turning these immune cells into warriors that kill and engulf microbes – and potentially the cancer too. “I think the infection changes the innate immune cells from helping the tumours to killing them,” says Henrik Schmidt at Aarhus University Hospital in Denmark. That, in turn, may also stimulate other parts of the immune system – such as our dendritic cells and T-cells – to learn to recognise the tumorous cells, so that they can attack the cancer again should it return.
Schmidt thinks that understanding the process of spontaneous remission is vital, since it could help refine the emerging class of “immunotherapies” that hijack our natural defences to combat cancer. In one treatment, for instance, doctors inject some cancer patients with inflammatory “cytokines” in order to kick the immune system into action. The side effects – such as high fever and flu-like symptoms – are typically treated with drugs like paracetamol, to improve the patient’s comfort.
But given that the fever itself may trigger remission, Schmidt suspected that the paracetamol might sap the treatment’s potency. Sure enough, he has found that more than twice as many patients – 25% versus 10% – survive past the two-year follow-up, if they were instead left to weather the fever.
There could be many other simple but powerful steps to improve cancer treatment inspired by these insights. One man experienced spontaneous remission after a tetanus and diphtheria vaccination, for instance – perhaps because vaccines also act as a call to arms for the immune system. Along these lines, Rashidi points out that a receiving standard vaccine booster – such as the BCG jab against tuberculosis – seems to reduce the chance of melanoma relapse after chemotherapy.
Catching a cure
Others are considering a far more radical line of attack. For instance, one approach aims to deliberately infect cancer patients with a tropical disease.
The technique, developed by American start-up PrimeVax, involves a two-pronged approach. It would begin by taking a sample of the tumour, and collecting dendritic cells from the patient’s blood. These cells help coordinate the immune system’s response to a threat, and by exposing them to the tumour in the lab, it is possible to programme them to recognise the cancerous cells. Meanwhile, the patient is given a dose of dengue fever, a disease normally carried by mosquitoes, before they are injected with the newly trained dendritic cells.
Under the supervision of doctors in a hospital, the patient would begin to develop a 40.5C fever, combined with the widespread release of inflammatory molecules – putting the rest of the immune system on red alert. Where the tumour was once able to lurk under the radar, it should now become a prime target for an intense attack from the immune cells, led by the programmed dendritic cells. “Dengue fever crashes and regroups the immune system, so that it is reset to kill tumour cells,” says Bruce Lyday at PrimeVax.
Infecting vulnerable patients with a tropical illness may sound foolhardy, but dengue fever is less likely to kill the average adult than the common cold – making it the safest choice of infection. Importantly, once the fever has subsided, the programmed immune cells will remain on the lookout for the tumour, should it reappear. “Cancer is a moving target. Most therapies attack from just one side – but we’re trying to put it in a lose-lose situation, now and in the future,” says Lyday.
No one could fault the ambition behind this kind of therapy. “Our mission is to replicate spontaneous remission in as standardised way as possible,” says Lyday’s colleague Tony Chen. Even so, they are keen to emphasise that their idea is still at a very early stage of development – and they cannot know how it will play out until they begin a clinical trial. The first tests, they hope, will begin with advanced melanoma patients, perhaps by the end of the year.
Clearly, caution is necessary. As Irvine points out: “Spontaneous remission is a little clue in a big complicated jigsaw.” But if – and that is a massive if – they succeed, the implications would be staggering. A rapid, relatively painless recovery from cancer is now considered a miracle. The dream is that it might just become the norm.


ΑΡΘΡΑ ΣΤΟ ΠΕΔΙΟ ΤΗΣ ΙΑΤΡΙΚΗΣ και ΒΙΟΛΟΓΙΑΣ

Abd,GM et al.2023. “Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise”.Frontiers in oncology vol. 13 1227884.

Abeles,SR, and Pride,DT.2014.“Molecular bases and role of viruses in the human microbiome”. Journal of molecular biology vol. 426,23: 3892-906.

Adebayo,M et al.2021.“Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis”. FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 35,6 : e21620.

Adeyinka,A,Bashir,K.2022.“Tumor Lysis Syndrome”.StatPearls, Treasure Island (FL): StatPearls Publishing.Νational Library of Medicine,USA.

Afrasiabi,K.2021.”Entropy and cancer: The Future of cancer therapeutics”.J Cancer Biol.2(3):62-67.
Ah-Thiane,L,Samimi,M,Kervarrec,T,Khammari,A, Dréno,B.2021.”Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review”. Eur J Dermatol. 31(3):381-391.

Ahern,S, Power, D, Hinchion ,J.2021.”Spontaneous Regression of a Pulmonary Metastasis Secondary to Contralateral Metastasectomy”.Annals of Thoracic Surgery 1;112(4):e249–51.
Ahmadi Moghaddam, P, Cornejo,KM, Hutchinson,L.2016.”Complete Spontaneous Regression of Merkel Cell Carcinoma After Biopsy: A Case Report and Review of the Literature”. Am J Dermatopathol.38(11):e154-e158.

Akkoc,Y et al.2021.“Autophagy and Cancer Dormancy”. Frontiers in oncology vol. 11 627023.

Al-Tawfiq,JA,Al-Khatti,AA.2007.”Spontaneous remission of acute monocytic leukemia after infection with Clostridium septicum”.Int J Lab Hematol. 29(5):386-389.

Alfarouk,KO,Stock,CM,Taylor,S. 2015.”Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp”. Cancer Cell Int. 2015;15:71.

Alix-Panabières,C,Riethdorf,S, Pantel, K.2008.” Circulating tumor cells and bone marrow micrometastasis”. Clin Cancer Res.14(16):5013-5021.

Aller,MA et al.2010.“Pathological axes of wound repair: gastrulation revisited”. Theoretical biology & medical modelling vol. 7 37.14.

Alqutub,A,Peck,D,Marotta,P.2011.”Spontaneous regression of a large hepatocellular carcinoma: case report”.Ger Med Sci. 9:Doc07.

Amiama-Roig,A et al.2022.“Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy”.Cancers vol. 14,20 5071.

Anderson,AR, Weaver,AM, Cummings,PT, Quaranta,V.2006.”Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment”. Cell. 127(5):905-915.

Andrejeva,G,and Rathmell,JC.2017.“Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors”. Cell metabolism vol. 26,1: 49-70.

Anin,SA,Vince,G,Quenby,S.2004.”Trophoblast invasion”. Hum Fertil (Camb). 7(3):169-174.

Anker,MS, Hadzibegovic. S, von Haehling, S.2020.”Effekte des Tumors auf Herz und Kreislauf [Tumor effects on the heart and circulation]”. Internist (Berl). 61(11):1120-1124.

Annaval,T et al.2020 “Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity”. Molecules (Basel, Switzerland) vol. 25,18 4215.

Annaval,T,Wild,R,Crétinon,Y,Sadir,R,Vivès,RR,Lortat-Jacob,H.2020. “Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity”. Molecules 25(18):4215.

Aoyama,M, Ozaki, T, Inuzuka, H.2005.”LMO3 interacts with neuronal transcription factor HEN2 and acts as an oncogene in neuroblastoma”.Cancer Res.65:4587–4597.


Apffel,CA, Arnason,BG, Twinam, CW, Harris,CA.1966.”Recovery with immunity after serial tapping of transplantable mouse ascites tumours”. Br J Cancer 20: 122-126.

Aranda-Anzaldo,A, and Myrna,AR..2021.“Is cancer a disease set up by cellular stress responses?”.Cell stress & chaperones vol. 26,4: 597-609.

Arias,JI et al.2012.“The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks”. Journal of oncology vol. 2012 : 521284.

Arias,JI,Aller,MA,Prieto,I. 2012.”The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks”. J Oncol. 521284.

Arias,Jose-Ignacio et al.2012."The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks". Journal of Oncology vol. 2012, Article ID 521284, 20 pages.

Ariza-Prota,M, Martínez,C,and Casan,P.2018.”Spontaneous regression of metastatic squamous cell lung cancer”. Clin Case Rep. 6:995-998.
Arnon,J et al.2001.”Genetic and teratogenic effects of cancer treatments on gametes and embryos”.Human Reproduction Update. 7 (4): 394–40.

Astiz,M et al.2019.“Mechanisms of Communication in the Mammalian Circadian Timing System”.International journal of molecular sciences vol. 20,2 343.

Atmanspacher,H.2020."The Pauli–Jung Conjecture and Its Relatives: A Formally Augmented Outline".Open Philosophy,vol. 3, no.1: 527-549.

Avanzi,S et al.2013. “How virus persistence can initiate the tumorigenesis process”. World journal of virology vol. 2,2: 02-9.

Averna ,R, Martelli, D, Migliorini, D, Saudelli ,M. 1980.”Micoplasmi e displasie della portio uterina [Mycoplasmas and dysplasia of the uterine cervix].” Boll Ist Sieroter Milan. 59(4):348-358.

Ayyar,VS, and Sukumaran,S.2021.“Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions”.Journal of pharmacokinetics and pharmacodynamics vol. 48,3: 321-338.

Bai,S et al.2022.“Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis”.Frontiers in cell and developmental biology vol. 10 752818.

Bailar IIIrd,JC,and Smith, EM.1987.”Have we reduced the risk of getting cancer or of dying from cancer? An update”. Med Oncol Tumor Pharmacother. 4(3-4):193–8.

Balzer,BL,Ulbright,TM.2006.”Spontaneous regression of testicular germ cell tumors. An analysis of 42 cases”.Am J Surg Pathol.30:858–865.
Banerji,CR,Miranda-Saavedra,D,Severini,S.2013.”Cellular network entropy as the energy potential in Waddington's differentiation landscape”. Sci Rep.3:3039

Baramiya,Mamuka G, and Baranov,E.2020.“From cancer to rejuvenation: incomplete regeneration as the missing link (Part I: the same origin, different outcomes)”. Future science OA vol. 6,3 FSO450.

Barcellos-Hoff,M.H,and Medina,D.2004.”New highlights on stroma–epithelial interactions in breast cancer”.Breast Cancer Res 7, 33.

Barkan,D,Green,JE,Chambers,AF. 2010.”Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth”. Eur J Cancer 46:1181–1188.

Barnetson,RS ,and Halliday,GM.1997.”Regression in skin tumours: a common phenomenon”. Australas J Dermatol. 38 Suppl 1:S63-S65.

Barrett,JC,and Wiseman,RC.1987.“Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment”. Environmental health perspectives vol. 76 : 65-70.

Bartels,K,Grenz,A,Eltzschig,HK.2013.”Hypoxia and inflammation are two sides of the same coin”. Proc Natl Acad Sci U S A.110(46):18351-18352.

Bassingthwaighte,JB.1992.“FRACTAL VASCULAR GROWTH PATTERNS.” Acta stereologica vol. 11,Suppl 1: 305-319.

Basso Ricci, S, Coradini, D, Di Fronzo,G,Bartoli,C,Villa,S.1998.”Estrogen receptor status of patients subjected to mastectomy for breast cancer with a disease-free interval of no less than 8 years”. Am J Clin Oncol.21:250–252.
Basso Ricci, S.2007.”Dialysis membrane and metastatic cancer cells”.Clin Nephrol. 68:354–356.
Basso Ricci,S. 2005.Letter to the editor. Med Hypothesis 64:428–431.
Basson,MA.2012.“Signaling in cell differentiation and morphogenesis”.Cold Spring Harbor perspectives in biology vol. 4,6: a008151.

Bayat Mokhtari,R et al.2017. “Combination therapy in combating cancer.” Oncotarget vol. 8,23: 38022-38043.

Bazire, L, De Rycke, Y, Asselain, B, Fourquet ,A, Kirova, YM. 2017.”Risks of second malignancies after breast cancer treatment: Long-term results”. Cancer Radiother. 21(1):10-15.

Beijers,AJ,Jongen,JL,Vreugdenhil,G.2012.”Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies”The Netherlands Journal of Medicine 70 (1): 18–25.

Belmonte-Mateos,C, and Pujades,C.2022. “From Cell States to Cell Fates: How Cell Proliferation and Neuronal Differentiation Are Coordinated During Embryonic Development”. Frontiers in neuroscience vol. 15 781160.

Benedetti,Francesca et al.2020.“Mycoplasmas-Host Interaction: Mechanisms of Inflammation and Association with Cellular Transformation”. Microorganisms vol. 8,9 1351.

Benner,B et al.2019.“Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro”. Journal for immunotherapy of cancer vol. 7,1 140.

Benninghoff,A.1936.”Form und Funktion”. Z.ges.Naturwiss 2: 1-9.

Benveniste,MF,et al.2019.”Recognizing Radiation Therapy-related Complications in the Chest”.RadioGraphics. 39 (2): 353.

Bera,TK,Tsukamoto,T,Panda,D,Huang,T,Guzman,RC,Hwang,SI,Nandi,S.1998.”Defective retroviral insertion activates c-Ha-ras proto-oncogene in an MNU-induced rat mammary carcinoma”.Biochemical and Biophysical Research Communications 248:835–840.

Bernard,C.1865. “Introduction à l’étude de la Médecine Expérimentale”. J. B. Baillière et Fils, Paris, English Translation by H. C. Greene, New York, NY: Dover Publications, Inc; 88–89.

Bertolaso M.2009.”The neoplastic process and the problems with the attribution of function”. Riv Biol.102(2):273-295.

Bhatia, Ranvir et al.2023.“Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy”. Biomedicines vol. 11,6 1614.

Bhave,M, Akhter,N,Rosen,ST.2014.”Cardiovascular toxicity of biologic agents for cancer therapy”. Oncology (Williston Park)28(6):482-490.

Bhutta ,B,Alghoula,F,and Berim,I.2024.”Hypoxia”. In: StatPearls [Internet]. Treasure Island (FL):StatPearls Publishing. Available from: https:// www. ncbi.nlm.nih.gov/ books/ NBK482316//.

Bilalović,N et al.2006. “The role of the stroma in carcinogenesis”. Bosnian journal of basic medical sciences vol. 6,1 : 33-8.

Billman,GE.2020. “Homeostasis: The Underappreciated and Far Too Often Ignored Central Organizing Principle of Physiology.” Frontiers in physiology vol. 11 200. 10.

Bissell,MJ,Hall,HG,Parry,G.1982.”How does the extracellular matrix direct gene expression?”. J Theor Biol 99: 31–68.

Bizzarri ,M, Cucina A.2014.”Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?”.Biomed Res Int.:934038.

Bizzarri,M,Cucina,A,Biava,PM.2011.“Embryonic morphogenetic field induces phenotypic reversion in cancer cells. Review article”. Curr Pharm Biotechnol. 12(2):243-253.

Bizzarri,M,Cucina,A,Biava,PM..2011.”Embryonic morphogenetic field induces phenotypic reversion in cancer cells. Review article”.Curr Pharm Biotechnol. 12(2):243-253.

Blyth,BJ,Cole,AJ,MacManus,MP,Martin,OA.2018.”Radiation therapy-induced metastasis: radiobiology and clinical implications”. Clin Exp Metastasis 35(4):223-236.

Boguszewska,K et al.2020.“The Similarities between Human Mitochondria and Bacteria in the Context of Structure, Genome, and Base Excision Repair System”. Molecules (Basel, Switzerland) vol. 25,12 2857.

Boguszewska,K,Szewczuk,M,Kaźmierczak-Barańska,J,Karwowski,BT. 2020.”The Similarities between Human Mitochondria and Bacteria in the Context of Structure, Genome, and Base Excision Repair System”. Molecules 25(12):2857.

Bokemeyer,C,Kuczyk ,MA, Kohne,CH.1996.”Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis”. Med Klin. 91(11):703–10.

Borbolis,F et al.2023.“The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration”. Cells vol. 12,3 429.

Bolukbas,MK,Ozdemir,C,Uzel,EK.2024.”Abscopal Effect-Induced Spontaneous Regression of Distant Metastases in Malignant Mesenchymal Tumor: A Case Report”.Front. Oncol.Sec. Cancer Immunity and Immunotherapy .Volume 14.

Borrmann,H,McKeating,JA,Zhuang,X.2021.”The Circadian Clock and Viral Infections”. Journal of Biological Rhythms 36(1):9-22.

Branch,S,Maloney,K,Purcell SM.2018.”Spontaneous regression of Merkel cell carcinoma”. Cutis 101(4):301-305.

Braun,S,Vogl,FD,Naume,B.2005.” A pooled analysis of bone marrow micrometastasis in breast cancer”. N Engl J Med. 353(8):793-802.

Bremnes,RM, Dønnem,T, Al-Saad ,S.2011.” The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer”. J Thorac Oncol. 6(1):209-217.

Briedis D, Seagrave,RC.1984.”Energy transformation and entropy production in living systems I. Applications to embryonic growth”.J Theor Biol. 110(2):173-193.

Brooks,AG,Posch,PE,Scorzelli,CT,Borrego,F,Coligan,JE.1997.”NKG2A complexed with CD94 defines a novel inhibitory natural kill cell receptor”.J Exp Med.185:795–800.
Brydøy,M, Fosså,SD, Dahl,O, Bjøro,T.2007."Gonadal dysfunction and fertility problems in cancer survivors". Acta Oncologica 46 (4): 480–9.

Buijs, M, Geschwind, JFH, Syed, LH, Ganapathy-Kanniappan, S, Kunjithapatham, R.2012.” Spontaneous regression in a syngeneic rat model of liver cancer: implications for survival studies”. J Vasc Interv Radiol 23: 1685-1691.

Bumpus,HJ.1928.”The apparent disappearance of pulmonary metastasis in a case of hypernephroma following nephrectomy”. J Urol .185.
Burton, GJ,Cindrova-Davies, T, Yung, HW, Jauniaux, E.2021. HYPOXIA AND REPRODUCTIVE HEALTH:Oxygen and development of the human placenta. Reproduction 161(1):F53-F65.

Burton,GJ, and Fowden,AL.2015.“The placenta: a multifaceted, transient organ”. Philosophical transactions of the Royal Society of London. Series B, Biological sciences vol. 370,1663 : 20140066.

Butel,JS.2000.”Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease”. Carcinogenesis 21(3):405-426.

Butterfield, LH.2015.” Cancer vaccines”. BMJ 350:988.
Caine,GJ,Stonelake,PS,Lip,GY,Kehoe,ST.2002.”The hypercoagulable state of malignancy: pathogenesis and current debate”. Neoplasia 4(6):465-473.

Calvo,W.1968.”The innervation of the bone marrow in laboratory animals”. Am J Anat. 123(2):315-328.

Canal,P, Chatelut,E, Guichard,S.1998.”Practical treatment guide for dose individualisation in cancer chemotherapy”. Drugs56(6):1019-1038.

Capitain,O, Asevoaia, A, Boisdron-Celle, M, Poirier,AL,Morel,A,Gamelin,E. 2012. "Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study". Clinical Colorectal Cancer 11 (4): 263–7.

Capp,JP et al.2021.“Group phenotypic composition in cancer.” eLife vol. 10 e63518.

Cardier,JE and Barbera-Guillem,E.1997.”Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells”.Hepatology 26(1):165-75.

Carrel,A.1935.”Man the unknown”.Harper & Brothers .

Carretero, C,Munoz-Navas, M, Betes,M, Angos,R, Subtil, JC, Fernandez-Urien, I . 2007."Gastroduodenal injury after radioembolization of hepatic tumors". The American Journal of Gastroenterology 102 (6): 1216–1220.

Castillejos-López,M,Romero,Y,Varela-Ordoñez,A2023.”Hypoxia Induces Alterations in the Circadian Rhythm in Patients with Chronic Respiratory Diseases”.Cells12 (23):2724.

Casás-Selves,M and Degregori,J.2011.“How cancer shapes evolution, and how evolution shapes cancer”. Evolution vol. 4,4 (2011): 624-634.

Cervinkova,M, Kucerova,P, Cizkova,J.2017.”Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?”. Anticancer Drugs 28(8):819-830.

Chabner,BA,Roberts,TG.2005."Timeline: Chemotherapy and the war on cancer". Nature Reviews. Cancer. 5 (1): 65–72.

Chadha,V, Shenoi,SD.2003. "Hair loss in cancer chemotherapeutic patients". Indian Journal of Dermatology, Venereology and Leprology 69 (2): 131–2.

Chadwick,J,Mann,WN.1950.”The Medical Works of Hippocrates: A New Translation from the Original Greek Made Especially for English Readers”. Oxford: Blackwell, 207.

Chambers ,AF, Groom ,AC ,MacDonald,IC.2002.”Dissemination and growth of cancer cells in metastatic sites”. Nat Rev Cancer 2: 563–572.

Chang,WY.2000.” Complete spontaneous regression of cancer: four case reports, review of the literature, and discussion of possible mechanism involved”. Hawaii Med J 59: 379-387.

Chartoumpekis,DV et al.2022.“Editorial: Microbiota and mitochondria: Impact on cell signaling, physiology, and disease”. Frontiers in microbiology vol. 13 1056499.

Chen, Qiong et al.2022. “A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis”. Frontiers in oncology vol. 12 944487.

Chen,Y, Takita,J,Choi,YL.2008.”Oncogenic mutations of ALK kinase in neuroblastoma”.Nature 455:971–974.
Chen,Z et al.2023.“Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions”.Signal transduction and targeted therapy vol. 8,1 70.

Chernet,B,and Levin,M.2013.“Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer”.Journal of clinical & experimental oncology vol. Suppl 1 (2013): S1-002.

Chernet,B,and Michael Levin.2013.“Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer”.Journal of clinical & experimental oncology vol. Suppl 1: S1-002.

Chiang, SP et al.2016.“Tumor cell intravasation.” American journal of physiology”.Cell physiology vol. 311,1 : C1-C14.

Chidambaram,M, Manavalan,R, Kathiresan,K.2011. "Nanotherapeutics to overcome conventional cancer chemotherapy limitations". Journal of Pharmacy & Pharmaceutical Sciences. 14 (1): 67–77.

Chin,KM, Chan,CY, Lee,SY.2018.” Spontaneous regression of pancreatic cancer: A case report and literature review”. Int J Surg Case Rep 42: 55-59.

Choe,A,et al.2022.”Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited?”. Cureus.14(12):e32505.

Choe,A,Mutsaers,A, Rodrigues,G, Chin,J, Leung,S, Winquist,E.2022.“Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited?”. Cureus 14(12):e32505.

Choi,HS,Lee,HM,Kim,WT.2014.”Detection of mycoplasma infection in circulating tumor cells in patients with hepatocellular carcinoma”. Biochem Biophys Res Commun 446(2):620-625.

Chung,C, Park, DI, Kim, SY.2015.”Spontaneous regression of non-small cell lung cancer that progressed after multiple chemotherapies: A case report”. Thorac Cancer 6(6):805-807.

Cimolai,N.2001.” Do mycoplasmas cause human cancer?” .Canadian Journal of Microbiology 47(8):691-697.

Clark,WH,Elder,DE,Guerry,D,Epstein,MN,Greene,MH,van Horn,M.1984.”A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma”. Human Pathol 15: 1147–65.

Clark,WH,Tucker,MA,Goldstein,AM.1995.”Parenchymal-stromal interactions in neoplasia.Theoretical considerations and observations in melanocytic neoplasia”. Acta Oncol.34(6):749-757.

Clark,WH.1995.”The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression”.Acta Oncol. 34(1):3-21.

Cole,WH.1976.”Spontaneous regression of cancer and the importance of finding its cause”. Natl Cancer Inst Monogr.44:5-9.

Cole,WH.1981.” Efforts to explain spontaneous regression of cancer”. J Surg Oncol. 17:201-209.
Cole,WH.1985.”The increase in immunosuppression and its role in the development of malignant lesions”. J Surg Oncol. 30:139–144.

Combray,J.2009.Synchronicity. Nature and Psyche in an Interconnected Universe. Texas: A&M University Press.

Cooper,JS,Hanley, ME,Hendriksen,S,Robins,M.2022.”Hyperbaric Treatment of Delayed Radiation Injury”.National Center for Biotechnology Information”.PMID 29261879.

Corrie,PG, Pippa,G.2008."Cytotoxic chemotherapy: clinical aspects". Medicine. 36 (1): 24–28.

Costantini,V and Zacharski ,LR.1992.”The role of fibrin in tumor metastasis”. Cancer Metastasis Rev 11(3-4):283-290.

Costanzo,Vet al.2018.“Exploring the links between cancer and placenta development”. Open biology vol. 8,6:180081.

Coussens,LM, and Werb,Z.2002.“Inflammation and cancer.” Nature vol. 420,6917: 860-7.

Cramer,W and Simpson,WL.1944.”Mast Cells in Experimental Skin Carcinogenesis “.Cancer Research Vol 4: 1-16.

Crespo,M,Leiva,M,Sabio,G.2021.“Circadian Clock and Liver Cancer”. Cancers(Bazel) 13(14): 1-14.

Croteau,R,Ketchum,RE,Long,RM,Kaspera,Rüdiger,W,Mark,R.2006.”Taxol biosynthesis and molecular genetics”. Phytochemistry Reviews. 5 (1): 75–97.

Cserni,G,Serfozo,O,Ambrózay,É,Markó,L,Krenács,L.2019.”Spontaneous pathological complete regression of high-grade triple-negative breast cancer with axillary metastasis”. Pol J Pathol. 70(2):139-143.

Cummins,J and Tangney,M.2013.”Bacteria and tumours: causative agents or opportunistic inhabitants?”.Infect Agent Cancer 8(1):11.

da Costa,REAR, Dos Reis, CA, Moura,RD, Araújo,ALN, de Oliveira,FTR, Vieira, SC.2021.”Cutaneous metastasis of occult breast cancer: a case report”. Pan Afr Med J. 40:23.

Dahlstrand,J,Collins,VP, Lendahl,U.1992.”Expression of the class VI intermediate filament nestin in human central nervous system tumors”. Cancer Res. 52(19):5334-5341.

Daley,D et al.2022.”Case report: Spontaneous remission of synchronous endometrial and ovarian cancers following pregnancy”.Front. Oncol., Sec. Gynecological Oncology.Volume 12 - 2022 |

Daly, ME, Monjazeb, AM, Kelly, K.2015.”Clinical trials integrating immunotherapy and radiation for non-small-cell lung cancer”. J Thorac Oncol.10:1685-1693.
Darby, S, McGale, P, Correa, C, Taylor, C, Arriagada, R, Clarke, M.2011. "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials". Lancet. 378 (9804): 1707–1716.

Davidson,EH.1993.”Later embryogenesis: regulatory circuitry in morphogenetic fields”. Development.118(3):665-690.

De Cicco,M.2004.”The prothrombotic state in cancer: pathogenic mechanisms”. Crit Rev Oncol Hematol.50(3):187-196.

de Groot ,PM, Wu, CC, Carter,BW, Munden,RF.2018.” The epidemiology of lung cancer”. Transl Lung Cancer Res. 7:220-233.
de Visser,KE,Eichten,A,Coussens,LM.2006.”Paradoxical roles of the immune system during cancer development”. Nat Rev Cancer.6:24–37.

De Weerd, JH, Hawthorne,J, Adson,MA.1977.”Regression of renal cell hepatic metastases following removal of primary lesions”. J Urol.117:790–792.
Delanian,S,Lefaix,JL,Pradat,PF.2012.”Radiation-induced neuropathy in cancer survivors”. Radiotherapy and Oncology 105 (3): 273–282.

Delorme-Axford,E,Sadovsky,Y,Coyne, CB.2014.”The Placenta as a Barrier to Viral Infections”.Annu Rev Virol.1(1):133-146.

Derman,AY, Nikac,, Haberman,S, Zelenko,N, Opsha,O, Flyer,M.2011.”MRI of placenta accreta: a new imaging perspective”.AJR Am J Roentgenol.197(6):1514-1521.

Devic,S.2016.“Warburg Effect-a Consequence or the Cause of Carcinogenesis?”. Journal of Cancer vol. 7,7 817-22.

DeVita,VT, Chu,E.2008.” A history of cancer chemotherapy”.Cancer Research. 68 (21): 8643–53.

Diaz-Cano,SJ.2012.“Tumor heterogeneity:mechanisms and bases for a reliable application of molecular marker design”.International journal of molecular sciences vol. 13,2 : 1951-2011.

Dickerson,EC,Davenport,MS, Liu,PS.2015.”Spontaneous regression of primary renal cell carcinoma following image-guided percutaneous biopsy”. Clin Imaging. 39(3):520-524.

Dikinson,RB,Lipman, ME.1998.”Growth regulation of normal and malignant breast epithelium”.In: Bland, K, Copeland, EM III, editors. The Breast: Comprehensive Management of Benign and Malignant Diseases. 2nd edition. Vol. 1. Philadelphia: WB Saunders. p. 518.
Dillekås,H,Rogers,MS,Straume,O.2019.”Are 90% of deaths from cancer caused by metastases?”. Cancer Med.8(12):5574-5576.
Dobson,RL,and Griffin,M.1962.”The histochemistry of cutaneous carcinogenesis. I. The dermis”.J Invest Dermatol.39:597-603.

Donaldson,DJ,Mason,JM.1975.”Cancer-related aspects of regeneration research: a review”.Growth 39(4):475-496.

Dussan,C, Zubor,P, Fernandez,M, Yabar,A, Szunyogh,N, Visnovsky,J.2008. “Spontaneous regression of a breast carcinoma: a case report”. Gynecol Obstet Invest. 65(3):206-211.

Ebben,JD et al.2010.“The cancer stem cell paradigm: a new understanding of tumor development and treatment”. Expert opinion on therapeutic targets vol. 14,6: 621-32.

Eftichiadou, C, Vartholomaios, AA, Salem, N, Destouni, E, Apostolidis, P. 1987.”Needle aspiration cytologic diagnosis of metastatic malignant melanoma of unknown primary origin: report of a case and review of the literature”. J Surg Oncol. 1987;35(4):253-255.

Egeblad, Mikala et al.2010.“Tumors as organs: complex tissues that interface with the entire organism”. Developmental cell vol. 18,6: 884-901.

Egel,R.2012.“Life's Order, Complexity, Organization, and Its Thermodynamic-Holistic Imperatives”. Life (Basel, Switzerland) vol. 2,4 323-63.

El-Badrawy,A.2017.”Multi-detector Computed Tomography (MDCT) Findings of Seven Cases with Spontaneous Regression of Hepatocellular Carcinoma”. Gulf J Oncolog.1(23):6-14.

El-Kassas,M,El Sheemy,RY, Sweedy,AT, Abdelmaksoud,AH.2023. “Spontaneous vanishing of hepatocellular carcinoma: A case report of an extremely rare incident”. J Cancer Res Ther.19(5):1447-1449.

Elad ,S, Zadik,Y, Hewson,I, Hovan,A, Correa,ME,Logan,R,Elting,LS, Spijkervet, FK, Brennan, MT.2010. "A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea". Supportive Care in Cancer 18 (8): 993–1006.

Elefteriou,F.2018.”Impact of the Autonomic Nervous System on the Skeleton”. Physiol Rev.98(3):1083-1112.

Elsenbruch,S,Enck,P.2017.”The stress concept in gastroenterology: from Selye to today”. F1000Res.6:2149.

Eltzschig,HK,and Carmeliet,P.2011.“Hypoxia and inflammation”.The New England journal of medicine vol. 364,7: 656-65.

Engel,P.1934.” Über den Infektionsindex der Krebskranken”.Wien Klin Wschr. 47:1118–1119.

Engel,P.1935.”Über den Einfluß des Alters auf den Infektionsindex der Krebskranken”. Wien Klin Wschr. 48:112.

Engstrand,J,Strömberg,C,Nilsson,H,Freedman,J,Jonas,E.2019.“Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition”.World J Surg Oncol. 17(1):228.

Engstrand,J,Strömberg,C,Nilsson,H,Freedman,J,Jonas,E.2019.”Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition”.World J Surg Oncol. 17(1):228.

Erren,T et al.2010. “Shift work and cancer: the evidence and the challenge”. Deutsches Arzteblatt international vol. 107,38 : 657-62.

Esplin,N,Fergiani,K,Legare,TB,Stelzer,JW,Bhatti,H,Ali,SK.2018. “Spontaneous regression of a primary squamous cell lung cancer following biopsy: a case report”. J Med Case Rep. 12(1):65.

Ettinger,L,and Doljanski,F.1992.”On the generation of form by the continuous interactions between cells and their extracellular matrix”. Biol Rev 67: 459–89.
Everson,T, Cole, W.1956.” Spontaneous regression of cancer: preliminary report”. Ann Surg. 144:366-383.
Everson, TC,and Cole WH.1959.”Spontaneous regression of malignant disease”. JAMA 169:1758-1759.
Falanga,A,Marchetti,M,Vignoli,A.2013.”Coagulation and cancer: biological and clinical aspects”. J Thromb Haemost. 11(2):223-233.

Fan,Y, Bergmann,A.2008.”Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!”.Trends Cell Biol.18(10):467-473.

Fenn,JE,Udelsman,R.2011."First use of intravenous chemotherapy cancer treatment: rectifying the record". Journal of the American College of Surgeons. 212 (3): 413–7.

Fernantez,A,Brada,M,Zabuliene,L,Karavitaki,N,Wass,JA.2009.”Radiation-induced hypopituitarism”. Endocrine-Related Cancer 16 (3): 733–772.

Ferrara P, Marrone G, Emmanuele V, et al.2008.”Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial”. Pediatr Nephrol.23(2):269-274.

Fishbein,AB et al.2021. “Circadian disruption and human health”. The Journal of clinical investigation vol. 131,19: e148286.

Forster,JC et al.2017. “A review of the development of tumor vasculature and its effects on the tumor microenvironment”. Hypoxia (Auckland, N.Z.) vol. 5 21-32.

Franklin,CI.1977.”Spontaneous regression of metastases from testicular tumours. A report of six cases from one centre”. Clin Radiol.28(5):499-502.

Franklin,DJ, Packel, L.2006."Cancer-related fatigue". Archives of Physical Medicine and Rehabilitation 87 (3 Suppl 1): S91–3, quiz S94–5.

Freites-Martinez,A, Shapiro,J, Goldfarb,S.2019.”Hair disorders in patients with cancer. J Am Acad Dermatol.80(5):1179-1196.

Fuster MM, Wang L.2010.”Endothelial heparan sulfate in angiogenesis”. Prog Mol Biol Transl Sci. 93:179-212.

Gabrilovich,D,Chen,H,Girgis,K,Cunningham,T,Meny,G,Nadaf, S.1996.” Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells”. Nat Med.2:1096–103.

Galmarini,CM.2020.”Lessons from Hippocrates: Time to Change the Cancer Paradigm”. International Journal of Chronic Diseases Volume 2020, Article ID 4715426: 1-14.

Gamelin,E, Delva,R, Jacob,J, Merrouche,Y, Raoul,JL,Pezet,D, Dorval, E, Piot G, Morel A. 2008.”Individual fluorouracil dose adjustment based on pharmacokinetic follow up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer”. Journal of Clinical Oncology 26 (13): 2099–105.

Gan To Kagaku Ryoho.1974.Cancer & Chemotherapy 46(13):2568-2570.National Library of Medicine.USA.https://www.ncbi.nlm.nih.gov/nlmcatalog/7810034

Ganzel,BL,Morris,PA,Wethington,E.2010.”Allostasis and the human brain: Integrating models of stress from the social and life sciences”. Psychol Rev. 117(1):134-174.

Gaussmann,AB,Imhoff,D,Lambrecht,E,Menzel,C,Mose,S.2006.”Spontaneous remission of metastases of cancer of the uterine cervix”. Onkologie. 29(4):159-161.

Gebauer,G, Fehm,T, Merkle,E, Beck, EP, Lang, N, Jäger, W.2001.”Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up”. J Clin Oncol.19(16):3669-3674.

Gerber,DE.2008. "Targeted therapies: a new generation of cancer treatments". American Family Physician. 77 (3): 311–9.

Gerstner,ER,Fine.RL.2007. "Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm". Journal of Clinical Oncology. 25 (16): 2306–12 .

Ghatalia,P, Morgan,CJ, Sonpavde,G.2016.”Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials”. Crit Rev Oncol Hematol. 98:122-136.

Gibson,RJ, Keefe, DM.2006."Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies". Supportive Care in Cancer 14 (9): 890–900.

Giese-Davis, Janine et al.2011.“Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. ”Journal of clinical oncology : official journal of the American Society of Clinical Oncology” vol. 29,4: 413-20.

Gill,P, Grothey,A, Loprinzi, C.2006. "Nausea and Vomiting in the Cancer Patient". Oncology: 1482–1496.

Gillette,MU,Tischkau,SA.1999.“Suprachiasmatic nucleus: the brain's circadian clock”. Recent Prog Horm Res.54:33-59.

Giroux,V, Rustgi,AK.2017.Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer.17(10):594-604.

Glen Chad,M et al.2019.“Agent-based modeling of morphogenetic systems: Advantages and challenges”.PLoS computational biology vol. 15,3 e1006577.

Goff,SP. 2001.” Retroviridae: The retroviruses and their replication”. In Fields virology, eds. D. M. Knipe, P. M. Howley, D. E. Griffin, M. A. Martin, R. A. Lamb, B. Roizman, and S. E. Straus, 5th ed., pp. 1999–2069. Philadelphia, Pennsylvania: Lippincott Williams and Wilkins.

Gofrit,ON et al.2022. “Patterns of metastases progression- The linear parallel ratio”. PloS one vol. 17,9 e0274942.

Goldenring,JR,and Jason CM.2022. “Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond.” Gastroenterology vol. 162,2 : 415-430.

Gomez, H,et al.1998.”Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis”. J Clin Oncol. 16(6): 2065–2069.

Gonzalez-Cao, María et al. 2016.“Human endogenous retroviruses and cancer.” Cancer biology & medicine vol. 13,4: 483-488.

Goodman,JW and Hodgson,GS.1962.”Evidence for stem cells in the peripheral blood of mice”. Blood 19:702–714.

Goodsell,DS.2002.”The molecular perspective: DNA topoisomerases”. Stem Cells. 20 (5): 470–1.

Gopu,P,Antony,F,Cyriac,S,Karakasis,K,Oza,AM.2021.”Updates on systemic therapy for cervical cancer”. Indian J Med Res. 154(2):293-302.

Gottfried,EB, Steller,R, Paronetto,F, Lieber,CS.1982.” Spontaneous regression of hepatocellular carcinoma”. Gastroenterology 82: 770-774.

Graça,LL,Lopes,S, Pereira Castro,J, Leite.F, Paupério,G.2024.”Not always a miracle - The case of the missing metastasis”.Port J Card Thorac Vasc Surg. 31(2):55-58. Published 2024 Jul 7.

Grandi,N, and Tramontano,E.2018.“Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses”. Frontiers in immunology vol. 9: 2039.